Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

[1]  Fanzhi Meng,et al.  T cell inflammation profile after surgical resection may predict tumor recurrence in HBV-related hepatocellular carcinoma. , 2016, International immunopharmacology.

[2]  H. Ditzel,et al.  Oncogenic cancer/testis antigens: prime candidates for immunotherapy , 2015, Oncotarget.

[3]  Y. Doki,et al.  NY-ESO-1 antibody as a novel tumour marker of gastric cancer , 2013, British Journal of Cancer.

[4]  R. Ueda,et al.  Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma. , 2012, Blood.

[5]  K. Ohshima,et al.  HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo , 2011, PLoS pathogens.

[6]  F. Balkwill,et al.  Human T-Lymphotropic Virus Type 1-Induced CC Chemokine Ligand 22 Maintains a High Frequency of Functional FoxP3+ Regulatory T Cells , 2010, The Journal of Immunology.

[7]  Kousuke Saito,et al.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) , 2009, Retrovirology.

[8]  Yuetsu Tanaka,et al.  High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1–specific CTL response , 2007, Blood.

[9]  L. Old,et al.  CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients. , 2005, Blood.

[10]  S. Jacobson,et al.  Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. , 2005, The Journal of clinical investigation.

[11]  N. Mueller,et al.  Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. , 2004, The Journal of infectious diseases.

[12]  William W. Kwok,et al.  Autoreactive T Cells in Healthy Individuals1 , 2004, The Journal of Immunology.

[13]  S. Izumo,et al.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.

[14]  S. Rosenberg,et al.  A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. , 1998, Journal of immunology.

[15]  D. Jäger,et al.  Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes , 1998, The Journal of experimental medicine.

[16]  Yao-Tseng Chen,et al.  A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Murphy,et al.  Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. , 1995, American journal of epidemiology.

[18]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[19]  S. Nagataki,et al.  Nationwide survey of HTLV‐I–associated myelopathy in Japan: Association with blood transfusion , 1990, Annals of neurology.

[20]  K. Tajima.  The 4th nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features , 1990, International journal of cancer.

[21]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[22]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[23]  K. Yamaguchi,et al.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[24]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[25]  R. Ferguson,et al.  LYMPHOID CELLS IN JEJUNAL MUCOSA , 1975, The Lancet.

[26]  Yao-Tseng Chen,et al.  NY-ESO-1: review of an immunogenic tumor antigen. , 2006, Advances in cancer research.

[27]  Yao-Tseng Chen,et al.  NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer. , 2003, Cancer immunity.

[28]  K. Arimura,et al.  HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. , 1995, Journal of neurovirology.

[29]  H. Towler,et al.  Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .